AVAC Ships 100,000 ASF Vaccine Doses to the Philippines After Commercial Approval

Vietnam → Philippines | Swine | African swine fever | September 29–30, 2026

Vietnamese animal-health company AVAC Vietnam JSC has shipped 100,000 doses of AVAC ASF LIVE to the Philippines following regulatory approval for commercial sale.

The shipment is the first tranche of a 300,000-dose commercial order and represents the largest single export batch of the vaccine to date, according to industry reporting.

The Philippine Bureau of Animal Industry approved AVAC ASF LIVE for commercial sale after a four-year review and field-monitoring programme involving more than 500,000 pigs.

AVAC ASF LIVE is a live attenuated, gene-deleted, freeze-dried vaccine developed against African swine fever.

The Philippines has suffered significant losses from ASF since the disease was first detected in the country in 2019. Commercial availability of an approved vaccine adds another disease-control tool alongside farm biosecurity, surveillance, movement controls and stamping-out measures.

The company is also pursuing international expansion. Indonesia is reportedly in the final stages of review, while India has approved trials and Malaysia is preparing trial approval.

Strategic / Analyst View

This is an important commercial milestone for the global swine-health industry because it demonstrates the progression of an ASF vaccine from development and field evaluation toward multinational commercial deployment.

The commercial opportunity extends beyond vaccine doses. Successful ASF control requires diagnostics, surveillance, cold-chain logistics, vaccination programmes, biosecurity and farm-level monitoring.

For Asian pork producers, vaccination could become an important component of integrated disease-management programmes, particularly in regions where smallholder production and frequent animal movement complicate biosecurity.

However, vaccine deployment should remain supported by regulatory oversight, strain matching, post-vaccination surveillance and appropriate biosecurity rather than being viewed as a standalone solution.